Literature DB >> 31997039

Multiple acyl-COA dehydrogenase deficiency in elderly carriers.

Francesco Macchione1, Leonardo Salviati2,3, Andrea Bordugo4, Monica Vincenzi5, Marta Camilot5, Francesca Teofoli5, Elia Pancheri1, Roberta Zordan2,3, Cinzia Bertolin2,3, Silvia Rossi2,3, Gaetano Vattemi1, Paola Tonin6.   

Abstract

Multiple acyl-CoA dehydrogenase deficiency, or glutaric aciduria type II, is an autosomal recessive disorder of fatty acid oxidation due to defects in electron transfer flavoprotein (ETF) encoded by ETFA and ETFB, or in electron transfer flavoprotein dehydrogenase (ETFDH) encoded by the ETFDH gene. The disease may present as a severe neonatal onset form and a mild late-onset form which is heterogeneous for the age at onset and clinical presentation. We describe two patients in their seventies, referred for a nonspecific myopathy, which resulted to manifest carriers of ETFDH gene mutation. Treatment with riboflavin and L-carnitine improved the clinical picture and the biochemical profile. This condition should be included in the differential diagnosis of myopathies even at an old age.

Entities:  

Keywords:  ETFDH gene mutations; Fatty acid oxidation; Late-onset multiple acyl-CoA dehydrogenase deficiency (MADD); Myopathy; Riboflavin treatment

Year:  2020        PMID: 31997039     DOI: 10.1007/s00415-020-09729-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  1 in total

1.  Glutaric acidemia type II. Comparison of pathologic features in two infants.

Authors:  A D Colevas; J L Edwards; R H Hruban; G A Mitchell; D Valle; G M Hutchins
Journal:  Arch Pathol Lab Med       Date:  1988-11       Impact factor: 5.534

  1 in total
  9 in total

1.  Comment on: "Multiple acyl‑CoA dehydrogenase deficiency in elderly carriers".

Authors:  Yılmaz Yıldız; Ayşegül Tokatlı
Journal:  J Neurol       Date:  2020-02-12       Impact factor: 4.849

2.  Screening of multiple acyl-CoA dehydrogenase deficiency in newborns and follow-up of patients.

Authors:  Duo Zhou; Meiling Ye; Zhenzhen Hu; Yu Zhang; Lin Zhu; Rulai Yang; Xinwen Huang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

Review 3.  Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs.

Authors:  Vincenzo Tragni; Guido Primiano; Albina Tummolo; Lucas Cafferati Beltrame; Gianluigi La Piana; Maria Noemi Sgobba; Maria Maddalena Cavalluzzi; Giulia Paterno; Ruggiero Gorgoglione; Mariateresa Volpicella; Lorenzo Guerra; Domenico Marzulli; Serenella Servidei; Anna De Grassi; Giuseppe Petrosillo; Giovanni Lentini; Ciro Leonardo Pierri
Journal:  Molecules       Date:  2022-05-29       Impact factor: 4.927

4.  Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.

Authors:  A Maguolo; G Rodella; A Dianin; R Nurti; I Monge; E Rigotti; G Cantalupo; L Salviati; S Tucci; F Pellegrini; G Molinaro; F Lupi; P Tonin; A Pasini; N Campostrini; F Ion Popa; F Teofoli; M Vincenzi; M Camilot; G Piacentini; A Bordugo
Journal:  Mol Genet Metab Rep       Date:  2020-08-05

5.  Late-onset multiple acyl-CoA dehydrogenase deficiency mimicking myositis in an elderly patient: a case report.

Authors:  Yiming Zheng; Yawen Zhao; Wei Zhang; Zhaoxia Wang; Yun Yuan
Journal:  BMC Neurol       Date:  2020-12-02       Impact factor: 2.474

Review 6.  An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Authors:  Federica Marra; Paola Lunetti; Rosita Curcio; Francesco Massimo Lasorsa; Loredana Capobianco; Vito Porcelli; Vincenza Dolce; Giuseppe Fiermonte; Pasquale Scarcia
Journal:  Biomolecules       Date:  2021-11-04

7.  Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects.

Authors:  Antonino Lupica; Rosaria Oteri; Sara Volta; Daniele Ghezzi; Selene Francesca Anna Drago; Carmelo Rodolico; Olimpia Musumeci; Antonio Toscano
Journal:  Front Neurol       Date:  2022-03-03       Impact factor: 4.003

8.  Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy.

Authors:  Hong Joo Kim; Payam Mohassel; Sandra Donkervoort; Lin Guo; Kevin O'Donovan; Maura Coughlin; Xaviere Lornage; Nicola Foulds; Simon R Hammans; A Reghan Foley; Charlotte M Fare; Alice F Ford; Masashi Ogasawara; Aki Sato; Aritoshi Iida; Pinki Munot; Gautam Ambegaonkar; Rahul Phadke; Dominic G O'Donovan; Rebecca Buchert; Mona Grimmel; Ana Töpf; Irina T Zaharieva; Lauren Brady; Ying Hu; Thomas E Lloyd; Andrea Klein; Maja Steinlin; Alice Kuster; Sandra Mercier; Pascale Marcorelles; Yann Péréon; Emmanuelle Fleurence; Adnan Manzur; Sarah Ennis; Rosanna Upstill-Goddard; Luca Bello; Cinzia Bertolin; Elena Pegoraro; Leonardo Salviati; Courtney E French; Andriy Shatillo; F Lucy Raymond; Tobias B Haack; Susana Quijano-Roy; Johann Böhm; Isabelle Nelson; Tanya Stojkovic; Teresinha Evangelista; Volker Straub; Norma B Romero; Jocelyn Laporte; Francesco Muntoni; Ichizo Nishino; Mark A Tarnopolsky; James Shorter; Carsten G Bönnemann; J Paul Taylor
Journal:  Nat Commun       Date:  2022-04-28       Impact factor: 17.694

Review 9.  Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism.

Authors:  Signe Mosegaard; Graziana Dipace; Peter Bross; Jasper Carlsen; Niels Gregersen; Rikke Katrine Jentoft Olsen
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.